Literature DB >> 10906732

Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures.

K Valko1, C M Du, C D Bevan, D P Reynolds, M H Abraham.   

Abstract

A fast-gradient high-performance liquid chromatographic (HPLC) method has been suggested to characterize the interactions of drugs with an immobilized artificial membrane (IAM). With a set of standards, the gradient retention times can be converted to Chromatographic Hydrophobicity Index values referring to IAM chromatography (CHI(IAM)) that approximates an acetonitrile concentration with which the equal distribution of compound can be achieved between the mobile phase and IAM. The CHI(IAM) values are more suitable for interlaboratory comparison and for high throughput screening of new molecular entities than the log k(IAM) values (isocratic retention factor on IAM). The fast-gradient method has been validated against the isocratic log k(IAM) values using the linear free energy relationship solvation equations based on the data from 48 compounds. The compound set was selected to provide a wide range and the least cross-correlation between the molecular descriptors in the solvation equation: (2) where SP is a solute property (e.g., logarithm of partition coefficients, reversed-phase (RP)-HPLC retention parameters, such as log k, log k(w), etc.) and the explanatory variables are solute descriptors as follows: R(2) is an excess molar refraction that can be obtained from the measured refractive index of a compound, pi(2)(H) is the solute dipolarity/polarizability, summation operatoralpha(2)(H) and summation operatorbeta(2)(0) are the solute overall or effective hydrogen-bond acidity and basicity, respectively, and V(x) is the McGowan characteristic volume (in cm(3)/100 mol) that can be calculated for any solute simply from molecular structure using a table of atomic constants. It was found that the relative constants of the solvation equation were very similar for the CHI(IAM) and for the log k(IAM). The IAM lipophilicity scale was quite similar to the octanol/water lipophilicity scale for neutral compounds. The effect of charge on the interaction with IAM was studied by varying the mobile phase pH. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906732     DOI: 10.1002/1520-6017(200008)89:8<1085::aid-jps13>3.0.co;2-n

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.

Authors:  Z Yu; A P IJzerman; L H Heitman
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

2.  Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

Authors:  Sandya R Beeram; Xiwei Zheng; Kyungah Suh; David S Hage
Journal:  Methods       Date:  2018-03-03       Impact factor: 3.608

Review 3.  Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies.

Authors:  Neil A Miller; Micaela B Reddy; Aki T Heikkinen; Viera Lukacova; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

4.  Modeling of Anticancer Sulfonamide Derivatives Lipophilicity by Chemometric and Quantitative Structure-Retention Relationships Approaches.

Authors:  Monika Pastewska; Beata Żołnowska; Strahinja Kovačević; Hanna Kapica; Maciej Gromelski; Filip Stoliński; Jarosław Sławiński; Wiesław Sawicki; Krzesimir Ciura
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

5.  Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign.

Authors:  Rosario Diaz; Sandra A Luengo-Arratta; João D Seixas; Emanuele Amata; William Devine; Carlos Cordon-Obras; Domingo I Rojas-Barros; Elena Jimenez; Fatima Ortega; Sabrinia Crouch; Gonzalo Colmenarejo; Jose Maria Fiandor; Jose Julio Martin; Manuela Berlanga; Silvia Gonzalez; Pilar Manzano; Miguel Navarro; Michael P Pollastri
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

6.  Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules.

Authors:  Andrew W Harrell; Caroline Sychterz; May Y Ho; Andrew Weber; Klara Valko; Kitaw Negash
Journal:  Pharmacol Res Perspect       Date:  2015-08-10

7.  Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging.

Authors:  Rareş-Petru Moldovan; Sylvia Els-Heindl; Dennis J Worm; Torsten Kniess; Michael Kluge; Annette G Beck-Sickinger; Winnie Deuther-Conrad; Ute Krügel; Peter Brust
Journal:  Int J Mol Sci       Date:  2017-04-05       Impact factor: 5.923

8.  Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs.

Authors:  Klara Valko; Silvia Rava; Shenaz Bunally; Scott Anderson
Journal:  ADMET DMPK       Date:  2020-01-31

9.  Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements.

Authors:  Chrysanthos Stergiopoulos; Fotios Tsopelas; Klara Valko
Journal:  ADMET DMPK       Date:  2021-06-06

10.  Affinity of Antifungal Isoxazolo[3,4-b]pyridine-3(1H)-Ones to Phospholipids in Immobilized Artificial Membrane (IAM) Chromatography.

Authors:  Krzesimir Ciura; Joanna Fedorowicz; Petar Žuvela; Mario Lovrić; Hanna Kapica; Paweł Baranowski; Wiesław Sawicki; Ming Wah Wong; Jarosław Sączewski
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.